Health care stocks were higher Monday afternoon, with the NYSE Health Care Index rising 1.4% and the Health Care Select Sector SPDR Fund (XLV) up 1.3%.
The iShares Biotechnology ETF (IBB) added 1.3%.
In corporate news, AstraZeneca (AZN) on Monday agreed to buy Belgian biotech company EsoBiotec in a deal worth up to $1 billion as it looks to boost its cell therapies portfolio. AstraZeneca shares were 0.1% higher.
Hyperfine (HYPR) shares surged 35% after the company said Monday it is collaborating with Nvidia (NVDA) to enhance its portable imaging technology.
Fortress Biotech (FBIO) shares popped 4.8%. The company and Partex said Monday that they're collaborating to identify and evaluate biopharmaceutical compounds using AI for potential acquisition or licensing by Fortress.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.